UroToday Partnership

The IBCG is thrilled to join forces with UroToday, a premier global hub for urology news and education. Together, we are committed to empowering patients through enhanced outreach and education on bladder cancer. By combining our strengths, we aim to equip patients with the latest information and resources they need to navigate their bladder cancer journey.

Global Society for Rare GU Tumors

In 2021, the IBCG and the Global Society of Rare GU Tumors (GSRGT) forged a powerful alliance by forming a joint committee focused on rare variants of bladder cancer. Recognizing the growing global health concern of bladder cancer, particularly the increasing incidence of rare variants, this committee unites experts from both organizations to collaborate on vital research, education, and clinical trial endpoints. Our shared goal is to advance the understanding and treatment of rare bladder cancer histologic subtypes and genetic variants.

Health Service Research

Under the visionary leadership of IBCG members, Drs. Stephen B. Williams and Yair Lotan, the Health Services Research (HSR) arm of the IBCG is forging a path towards becoming a global collaborative hub to enhance population-based health services research for bladder cancer. Through the development and utilization of robust databases and innovative research methodologies, the HSR team is dedicated to generating actionable insights to improve the quality, accessibility, and efficiency of bladder cancer care delivery worldwide.